91-105 of 639
Tailoring Treatment in Pediatric Meningitis: Age-Based Considerations
Clinician's RoundtableTailoring Treatment in Pediatric Meningitis: Age-Based Considerations
Beyond the Stiff Neck: Meningitis Detection in Infants and Toddlers
Clinician's RoundtableBeyond the Stiff Neck: Meningitis Detection in Infants and Toddlers
Addressing Barriers to MenB and MenACWY Vaccination
VacciNationAddressing Barriers to MenB and MenACWY Vaccination
Evaluating MenB Vaccines Beyond the Traditional hSBA Assay
VacciNationEvaluating MenB Vaccines Beyond the Traditional hSBA Assay
Pregnancy and Infant Outcomes in Multiple Sclerosis: Findings from the MAPLE-MS Pharmacovigilance Program
NeuroFrontiersPregnancy and Infant Outcomes in Multiple Sclerosis: Findings from the MAPLE-MS Pharmacovigilance Program
ASD in Children with SMA Type I: Diagnostic Challenges in a Multifactorial Context
NeuroFrontiersASD in Children with SMA Type I: Diagnostic Challenges in a Multifactorial Context
- advertisement
Safety and Efficacy of Onasemnogene Abeparvovec in Pediatric SMA Across Expanded Weight Cohorts
NeuroFrontiersSafety and Efficacy of Onasemnogene Abeparvovec in Pediatric SMA Across Expanded Weight Cohorts
COVID-19 Risks in Infants: The Case for Maternal Vaccination
Clinician's RoundtableCOVID-19 Risks in Infants: The Case for Maternal Vaccination
COVID-19 in Pregnant Individuals and Children: Vaccine Access and Advocacy
Clinician's RoundtableCOVID-19 in Pregnant Individuals and Children: Vaccine Access and Advocacy
Rethinking Contact Lenses for Myopic Kids: Why Age 7 Isn’t Too Young
Eye on Ocular HealthRethinking Contact Lenses for Myopic Kids: Why Age 7 Isn’t Too Young
Debunking Myopia Myths: Kids Are Safer Contact Lens Wearers Than You May Think
Eye on Ocular HealthDebunking Myopia Myths: Kids Are Safer Contact Lens Wearers Than You May Think
Moving Beyond Correction: WCO’s Standard of Care for Myopia Management
Eye on Ocular HealthMoving Beyond Correction: WCO’s Standard of Care for Myopia Management
- advertisement
Pediatric Sickle Cell Disease: Analyzing Trends in Medication Utilization
Project Oncology®Pediatric Sickle Cell Disease: Analyzing Trends in Medication Utilization
Evaluating Guselkumab for Pediatric Psoriasis: New Phase III Trial Data
DermConsultEvaluating Guselkumab for Pediatric Psoriasis: New Phase III Trial Data
Exploring Circulating CD34+ Cells as a Biomarker of Fracture Risk in DMD
NeuroFrontiersExploring Circulating CD34+ Cells as a Biomarker of Fracture Risk in DMD









































